Replies to post #236554 on Biotech Values

[dewophile]

Usually it takes some time to tell if an acquisition like this was smart. It’s fair to say this was at least a good deal for BMY and could end up as great
Happy new year to all

[jbog]

Because BMY had their original delay caused by lack of Documentation and now because the FDA inspection requirement you have to wonder if the Lawyers will start their parade.

It might have been convenient to not have a complete filing.

[DewDiligence]

BMY raises buyback authorization to $6.4B (from prior figure of $4.4B):

https://finance.yahoo.com/news/bristol-myers-squibb-announces-2-115900869.html

Some of this liquidity comes from not having to pay the CELG CVR.